Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells

Apoptosis : an International Journal on Programmed Cell Death
Xianfang LiuLing Su

Abstract

Epigenetic abnormalities are associated with non-small cell lung cancer (NSCLC) initiation and progression. Epigenetic drugs are being studied and in clinical trials. However, the molecular mechanism underlying the apoptosis by the epigenetic agents remains unclear. SUV39H1 is an important methyl-transferase for lysine 9 on histone H3 and usually related to gene transcriptional suppression, and chaetocin acts as the inhibitor of SUV39H1. We demonstrated here that chaetocin effectively suppressed the growth of multiple lung cancer cells through inducing apoptosis in a death receptor 5 (DR5)-dependent manner. Chaetocin treatment activated endoplasmic reticulum (ER) stress which gave rise to the up-regulation of ATF3 and CHOP. Furthermore, ATF3 and CHOP contributed to the induction of DR5 and subsequent apoptosis. When SUV39H1 was silenced with siRNA, the expression of ATF3, CHOP and DR5 was elevated. Thereafter, knockdown of SUV39H1 induced apoptosis in NSCLC cells. In summary, chaetocin pharmacologically inhibits the activity of SUV39H1 which provokes ER stress and results in up-regulation of ATF3 and CHOP, leading to DR5-dependent apoptosis eventually. These findings provide a novel interpretation on the anti-neoplastic activit...Continue Reading

References

Aug 1, 1981·Canadian Journal of Microbiology·S SekitaM Umeda
Aug 24, 2004·The Journal of Biological Chemistry·Hirohito Yamaguchi, Hong-Gang Wang
Oct 27, 2004·Cancer Science·Hideo YagitaKo Okumura
Dec 2, 2004·Journal of the National Cancer Institute·Xiangguo LiuShi-Yong Sun
Oct 11, 2005·Apoptosis : an International Journal on Programmed Cell Death·S-Y Sun
Nov 2, 2005·Nature Reviews. Molecular Cell Biology·Cyrus Martin, Yi Zhang
Jan 13, 2006·Nature Chemical Biology·Dorothea GreinerAxel Imhof
Sep 6, 2006·EMBO Reports·Eva SzegezdiAfshin Samali
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin Camphausen, Philip J Tofilon
Nov 13, 2008·Antioxidants & Redox Signaling·Jennifer D TibodeauKeith C Bible
Dec 2, 2008·Nature Reviews. Drug Discovery·Inki KimJohn C Reed
Jun 25, 2009·Nature Reviews. Cancer·Thomas G Cotter
Aug 26, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Matthew R ThompsonBryan R G Williams
Jun 10, 2010·Oncogene·F Gonzalvez, A Ashkenazi
Dec 9, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yoon-Mi LeeJong-Wan Park
Jul 6, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ling SuSunil Singhal
Sep 24, 2011·Nature Reviews. Cancer·Stephen B Baylin, Peter A Jones
Feb 8, 2013·Biomarkers in Medicine·Ioanna BalgkouranidouEvi S Lianidou
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 17, 2014·Oncology Reports·Lisheng CaiXingsheng Chen

❮ Previous
Next ❯

Citations

Aug 24, 2017·Environmental and Molecular Mutagenesis·Juliana Carvalho Alves-SilvaFelipe Saldanha-Araujo
Jun 10, 2020·The Journal of Infectious Diseases·Yasue TakeuchiKazuaki Chayama
Jul 7, 2020·Frontiers in Cell and Developmental Biology·Zhao YangChangyuan Yu
Apr 19, 2018·Frontiers in Immunology·Brianne CruickshankShashi Gujar
Jul 12, 2020·International Journal of Molecular Sciences·Pil-Soo JeongSun-Uk Kim
Nov 28, 2019·Cell Death & Disease·Ezgi Ozyerli-GoknarTugba Bagci-Onder
Dec 30, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Nirmalya Saha, Andrew G Muntean
Sep 1, 2021·European Journal of Pharmacology·Hangyu JiangLin Li
Sep 21, 2021·Frontiers in Cell and Developmental Biology·Ignacio Campillo-MarcosPedro A Lazo
Apr 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiang ZhangDezhi Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis